Champions Oncology Inc. (CSBR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Champions Oncology Inc.

    NASDAQ: CSBR · Real-Time Price · USD
    6.44
    -0.17 (-2.57%)
    At close: Sep 10, 2025, 3:59 PM
    6.65
    3.26%
    After-hours: Sep 10, 2025, 06:52 PM EDT

    Champions Oncology Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Revenue
    		 n/a 50.16M 53.87M 49.11M 41.04M
    Cost of Revenue
    		 28.39M 29.4M 29.53M 23.63M 21.47M
    Gross Profit
    		 -28.39M 20.75M 24.34M 25.48M 19.57M
    Operating Income
    		 4.55M -7.36M -4.45M 607K 338K
    Interest Income
    		 n/a n/a n/a n/a n/a
    Pretax Income
    		 4.63M -7.31M -5.27M 583K 409K
    Net Income
    		 4.7M -7.28M -5.33M 548K 362K
    Selling & General & Admin
    		 16.88M 18.13M 17.24M 15.5M 12.03M
    Research & Development
    		 6.83M 9.54M 11.54M 9.37M 7.2M
    Other Expenses
    		 293K 435K -11K -24K 71K
    Operating Expenses
    		 24M 28.11M 28.79M 24.87M 19.23M
    Interest Expense
    		 n/a n/a n/a 24K n/a
    Selling & Marketing Expenses
    		 7.54M 7.06M 7M 6.38M 5.52M
    Cost & Expenses
    		 52.39M 57.51M 58.32M 48.5M 40.7M
    Income Tax Expense
    		 -75K -32K 68K 35K 75K
    Shares Outstanding (Basic)
    		 13.66M 13.55M 13.54M 13.2M 13.14M
    Shares Outstanding (Diluted)
    		 14.27M 13.55M 13.54M 14.16M 14.57M
    EPS (Basic)
    		 0.34 -0.54 -0.39 0.04 0.03
    EPS (Diluted)
    		 0.33 -0.54 -0.39 0.04 0.02
    EBITDA
    		 4.55M -5.05M -2.07M 2.23M 366K
    EBIT
    		 n/a -6.92M -4.45M 583K 437K
    Depreciation & Amortization
    		 n/a 1.87M 3.2M 2.41M 1.58M

    Add to Watchlist